These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticholinergic properties of the antischistosomal drug hycanthone. Hillman GR; Senft AW Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369 [TBL] [Abstract][Full Text] [Related]
5. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Nilvebrant L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114 [TBL] [Abstract][Full Text] [Related]
6. Antimuscarinic oxotremorine analogs distinguish high and low affinity agonist states of muscarinic receptors. Ringdahl B; Amstutz R; Closse A Proc West Pharmacol Soc; 1988; 31():57-60. PubMed ID: 3211922 [No Abstract] [Full Text] [Related]
7. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]
8. Anticholinergic action of disopyramide in intestinal smooth muscle of the guinea pig: inhibition of muscarinic receptors (M1 and M2). Ishida Y; Mizukami M; Taniguchi T; Satake N; Fujiwara M; Shibata S Jpn J Pharmacol; 1990 Feb; 52(2):363-70. PubMed ID: 1690310 [TBL] [Abstract][Full Text] [Related]
9. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one. Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004 [TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs. Pica-Mattoccia L; Cioli D J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347 [TBL] [Abstract][Full Text] [Related]
11. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships. Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246 [TBL] [Abstract][Full Text] [Related]
12. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977 [TBL] [Abstract][Full Text] [Related]
13. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent. Carroll FI; Abraham P; Parham K; Griffith RC; Ahmad A; Richard MM; Padilla FN; Witkin JM; Chiang PK J Med Chem; 1987 May; 30(5):805-9. PubMed ID: 3494849 [TBL] [Abstract][Full Text] [Related]
14. Effects of hycanthone on neuromuscular systems of Schistoma mansoni. Tomosky-Sykes TK; Bueding E J Parasitol; 1977 Apr; 63(2):259-66. PubMed ID: 870666 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological activity and receptor-binding characteristics of 2 beta-(2'-phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane and its optical isomers. Gao ZG; Cui WY; Wang L; Liu CG Arch Int Pharmacodyn Ther; 1996; 331(2):124-35. PubMed ID: 8937624 [TBL] [Abstract][Full Text] [Related]
16. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related]
17. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists. Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510 [TBL] [Abstract][Full Text] [Related]
18. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
19. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates. Lee JH; el-Fakahany EE J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]